BANNER1
BANNER2
BANNER3-1

About our company

What do we do?

Jiangxi ZhuoRuiHua Meidical instruments Co., Ltd. is mainly engaged in the R&D, manufacturing and sales of endoscopic diagnostic instruments and consumables. We’re committed to providing superior quality, affordable and durable products to hospitals and clinics within the reach of healthcare professionals worldwide.

view more

Hot products

Our products

MISSION

ZRH med are committed to continuous product improvement and refinement to provide users with high-quality products and services.

INQUIRY NOW
  • Competitive price gains you greater profit margin

    Affordable

    Competitive price gains you greater profit margin

  • Strict quality control to ensure the good quality of our products which gains you good reputation as well as trust from your end clients.

    Safety Assurance

    Strict quality control to ensure the good quality of our products which gains you good reputation as well as trust from your end clients.

  • Professional R&D team and continuous investment to complete the product chain which gains you more chance in the market.

    Expertise

    Professional R&D team and continuous investment to complete the product chain which gains you more chance in the market.

Latest information

news

news_img
Glad to inform you that we are attending Medica 2022 at the DÜSSELDORF Germany. MEDICA is the world’s largest event for the medical sector. For more than 40 years it has been firmly established on every expert’s calendar. There are many reasons why MEDICA is so unique. F...

Medica 2022 From 14th to 17th November 2022 – DÜSSELDORF

Glad to inform you that we are attending Medica 2022 at the DÜSSELDORF Germany. MEDICA is the world’s largest event for the medical sector. For more than 40 years it has been firmly established on every expert’s calendar. There are many reasons why MEDICA is so unique. F...

Common malignant tumors of digestive tract, prevention and screening program (2020 edition)

In 2017, the World Health Organization proposed the strategy of "early detection, early diagnosis, and early treatment", which is intended to remind the public to pay attention to symptoms in advance. After years of clinical real money, these three strategies have become...